CROS NT
Alira Health is a global life sciences consultancy and CRO delivering integrated regulatory, clinical, biometrics, market access, and real-world evidence services to pharmaceutical, biotech, medical device, and digital health clients across 13+ countries.
- Company typePrivate
- Founded1999
- HeadquartersVerona, Italy
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CROS NT does
Alira Health is a global life sciences advisory and contract research organization (CRO) operating across the full product lifecycle for pharmaceutical, biotechnology, medical device, and digital health clients. The company is legally CMC Consulting Boston, Inc. (d/b/a Alira Health), headquartered in Framingham, Massachusetts, and grew from a boutique consultancy of fewer than 30 employees (acquired via leveraged buyout in 2015 by current CEO Gabriele Brambilla) to over 800 employees across the Americas, EMEA, and Asia-Pacific (13+ countries including the USA, UK, France, Germany, Italy, Spain, Switzerland, Ireland, Sweden, Denmark, the Netherlands, Portugal, Japan, and Australia). The firm is privately held and majority-controlled by its CEO, who also chairs the Drug Delivery Systems Center of Excellence; the Board was expanded in January 2026 with Bill Achtmeyer and George G. Montgomery (Chairman). The CROS NT biometrics operation, founded in Verona, Italy in 1992 (with bolt-on acquisitions of Stat-Tech Services in 2013 and MDSL International in 2014), is part of Alira Health's biometrics service line providing biostatistics, data management, and statistical programming for clinical trials.
The company's service portfolio is organized into Research and Clinical Development Solutions (Regulatory, Clinical, Biometrics, CMC, Clinical Development Consulting), Consulting (Management Consulting, Market Access, Patient Engagement, Transaction Advisory), Real-World Solutions, and a dedicated Biotech offering. Its proprietary technology surface centers on SpherePX™, a platform launched January 2025 for real-world evidence collection and patient engagement, and Health Storylines™, a digital patient engagement tool. Complementary intellectual property includes the Patient Engagement Certification program (launched June 2025) and a publishing franchise of annual industry reports covering biologics CDMO (the market reached $23.2B in 2025), medtech CDMO ($96.5B in 2025, projected to $143.6B by 2030 at 8.3% CAGR), and global drug delivery systems.
Revenue is generated through customized professional services engagements priced on a quote basis under multi-year contracts, supplemented by sales of industry research reports and the Patient Engagement Certification program. Go-to-market is direct enterprise sales supported by an event-driven presence (BIO, CPHI, MedTech World, ASCO, EULAR), the annual Global Payer Forum (2,000+ live attendees from 87 countries in 2025), and thought-leadership content. The company secured up to $100 million in growth debt from Symbiotic Capital in December 2024 to fund expansion, and maintains named engagements with Gustave Roussy (cancer prevention), Lipogems (knee osteoarthritis FDA IDE study), Scottsdale Research Institute (psilocybin for PTSD), and Infuse Life Science (Japan medical devices).
CROS NT firmographics
Firmographics- Name
- CROS NT
- Legal name
- CMC Consulting Boston, Inc. d/b/a Alira Health
- Website
- https://crosnt.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Alira Health is a global life sciences consultancy and CRO delivering integrated regulatory, clinical, biometrics, market access, and real-world evidence services to pharmaceutical, biotech, medical device, and digital health clients across 13+ countries.
- Ownership category
- akta.pro rank
CROS NT industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Other Scientific and Technical Consulting Services (541690), Scientific Research and Development Services (5417)
- akta.pro primary industry
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
- akta.pro secondary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
Keywords
Where CROS NT is headquartered
LocationHeadquarters
- HQ city
- Verona
- HQ country
- Italy
- HQ region
- Europe
Offices2 records
Markets served
CROS NT business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Strategic Consulting Services: Management consulting, market access consulting, regulatory consulting, transaction advisory, and clinical development consulting services provided to life sciences companies.
- CRO Services: Clinical research organization services including clinical operations, biometrics, CMC (Chemistry, Manufacturing and Controls), and clinical development consulting for pharmaceutical and biotech clients.
- Research and Reports: Market research reports and white papers on CDMO markets, biologics, medtech, drug delivery systems, and other healthcare sectors sold to clients and made available for download.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise consulting and CRO services |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels9 records
CROS NT product offering
Product offeringCore offering
CROS NT is a global team of passionate specialists that deliver innovative, high quality, tailored biometrics solutions. The company focuses on biometrics services for clinical research, including biostatistics, clinical data management, and statistical programming delivered to study sponsors.
Product overview
Alira Health is a global healthcare consultancy offering an integrated platform of strategic consulting, CRO (Contract Research Organization) services, and technology solutions. The company's portfolio centers on patient-enabled innovation through its technology platforms (SpherePX™ for real-world evidence collection and Health Storylines™ for patient engagement), complemented by a Patient Engagement Certification program. Services span the full product lifecycle including Regulatory, Clinical, Biometrics, CMC, Clinical Development Consulting, Management Consulting, Market Access, Patient Engagement, Transaction Advisory, and Real-World Solutions. The company serves life sciences organizations across pharmaceuticals, biotech, medical devices, and digital health to accelerate development, improve access, and deliver measurable patient outcomes.
Differentiator
Problem solved
Functional benefit
Brands
- SpherePX: Next-generation technology platform designed to drive RWE collection and elevate patient engagement and retention.
- Health Storylines
- RedCrow
- Patient Engagement Certification
- Global Payer Forum
Products and services
- Biometrics Solutions Tailored biometrics services for clinical research sponsors, encompassing biostatistics, clinical data management, and statistical programming delivered to pharmaceutical, biotech, and medical device companies running clinical trials.
Quantifiable outcome
- 96% of Global Payer Forum respondents reported improved value-based healthcare knowledge
- +1 more outcomes
Companies that use CROS NT
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles1 record
CROS NT technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration13 records
Feature3 records
CROS NT partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered regional, core and minor.
- Infuse Life ScienceregionalRegional partnership combining iLS's Japan-rooted medical device and diagnostics expertise with Alira Health's comprehensive global life sciences strategy focused on pharmaceuticals and biotech to advance healthcare innovation.
- Patient Focused Medicines Development (PFMD)coreCoalition dedicated to enabling patient engagement by providing frameworks and collaborative networks needed to make patient-centered healthcare a worldwide reality. Alira Health joined to advance patient-centered evidence generation.
- Autoimmune Neurology Alliance (AiNA)coreLaunched AXIS Registry - a new initiative to advance research and improve patient care in autoimmune neurological diseases including myasthenia gravis. Registry will collect patient-centered information for 10 years.
- Wound Care Collaborative Community (WCCC)coreFirst Platinum CRO Partner of the Wound Care Collaborative Community, expanding ongoing work to advance wound healing innovation through patient-centered approaches.
- Gustave RoussycoreCommercial partner overseeing digital development of Project Interception - a pioneering cancer prevention initiative led by one of the world's top cancer research institutes.
- RepublicminorStrategic partnership between RedCrow (Alira Health company) and Republic to reshape healthcare crowdfunding landscape. Republic has an investor network of over 3 million users.
- AseBiominorSecond edition of Mentoring Program in Market Access for SMEs - supporting and driving market access for innovation from small Spanish biotechnology companies.
- BiocatminorStartup Support Program 2024 - promoting second annual program focused on helping advanced and emerging therapies companies in the BioRegion of Catalonia reach the market.
- American Podiatric Medical Association (APMA)minorCorporate membership to help advance APMA's Podiatric Registry - the largest professional association representing podiatrists, physicians and surgeons treating foot and ankle.
- FORWARDcorePartnership with national database for rheumatic diseases to create enhanced patient registry for autoimmune disease Lupus.
- Myasthenia Gravis Foundation of America (MGFA)corePartnership to relaunch and enhance patient registry for people with myasthenia gravis, capitalizing on technological advances for clinical research.
- MassMEDICminorCollaboration on annual U.S. MedTech Contract Manufacturing (CDMO) reports; Massachusetts Medical Device Industry Council.
Scale indicators5 records
Recent moves6 records
Expansion highlights7 records
CROS NT competitors and assessment
Company assessmentDirect peers
- Cytel: Cytel is a leading pure-play biostatistics and biometrics CRO offering statistical programming, data management, and adaptive trial design services to biopharma sponsors globally — the closest direct specialist peer to CROS NT in the biometrics CRO niche.
- Clario: Clario (formed from the merger of ERT and Bioclinica) provides clinical trial endpoint technologies and biometrics services including eCOA, imaging, and respiratory diagnostics, with deep biostatistics/data management capabilities that overlap directly with CROS NT's offering.
- eClinical Solutions: eClinical Solutions (elluminate platform) provides clinical data management, biostatistics, and analytics services to life sciences sponsors — a direct competitor to CROS NT in biometrics-focused clinical trial services.
- Premier Research: Premier Research is a mid-sized CRO with strong biometrics, biostatistics, and clinical development capabilities serving biotech and specialty pharma — a comparable-sized direct competitor to CROS NT in the specialist CRO segment.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a global mid-market CRO providing biometrics, biostatistics, and full-service clinical development — directly comparable to CROS NT on biometrics depth and target customer (mid-tier biopharma).
- Theorem Clinical Research: Theorem Clinical Research is a mid-sized CRO providing biometrics, data management, and clinical research services to biopharma — a directly comparable scale peer to CROS NT.
Broad incumbents
- IQVIA: IQVIA is the largest global CRO with extensive biometrics and biostatistics capabilities offered alongside its full-service clinical, commercial, and real-world evidence portfolio — a broad incumbent whose biometrics unit competes head-to-head with specialist CROs like CROS NT.
- ICON plc: ICON plc is a top-3 global CRO with substantial biostatistics, data management, and statistical programming services offered as part of its integrated clinical development platform — competes with CROS NT in biometrics work as part of larger bundled deals.
- Charles River Laboratories: Charles River Laboratories operates a global CRO/biopharma services business including biostatistics and clinical data management, serving as a broad incumbent competitor that frequently bundles biometrics with its larger discovery and development offerings.
Emerging players
- Medidata (Dassault Systèmes): Medidata provides the Rave clinical trial platform and increasingly offers biometrics-adjacent data management and analytics services — an emerging player whose technology-driven model intersects with traditional biometrics CROs like CROS NT.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights4 records
Customer concentration
CROS NT social profiles
Digital presenceCROS NT compliance and trust
Trust signalCompliance5 records
CROS NT financial estimates
Financial estimateRevenue estimate
Valuation estimate
CROS NT leadership team
Management profileNumber of profiles
CROS NT subsidiaries and ownership
Company hierarchySubsidiaries1 record
CROS NT funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CROS NT M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CROS NT
What does CROS NT do?
CROS NT is a global team of passionate specialists that deliver innovative, high quality, tailored biometrics solutions. The company focuses on biometrics services for clinical research, including biostatistics, clinical data management, and statistical programming delivered to study sponsors.
Is CROS NT a public or private company?
CROS NT is a private company. It is classified as unknown and is currently operating.
When was CROS NT founded?
CROS NT was founded in 1999. It employs 11 to 50 people.
Where is CROS NT based?
CROS NT is headquartered in Verona, Italy, in the Europe region.
How does CROS NT make money?
Three revenue lines are on record. Strategic Consulting Services are the primary driver. The others are CRO Services and research and Reports.
Who are CROS NT's main competitors?
Direct peers on record are Cytel, Clario, eClinical Solutions, Premier Research, Worldwide Clinical Trials and Theorem Clinical Research. Broad incumbents are IQVIA, ICON plc and Charles River Laboratories. Medidata (Dassault Systèmes) is listed as an emerging player.
Does CROS NT have an API?
No public API is recorded for CROS NT.
What industry is CROS NT in?
CROS NT's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs, with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 541690.